AAAAAA

   
Results: 1-10 |
Results: 10
Bayesian approaches to technology assessment and decision making
Authors: Luce, BR Shih, YCT Claxton, K
Citation: Br. Luce et al., Bayesian approaches to technology assessment and decision making, INT J TE A, 17(1), 2001, pp. 1-5
Bayesian value-of-infomation analysis - An application to a policy model of Alzheimer's disease
Authors: Claxton, K Neumann, PJ Araki, S Weinstein, MC
Citation: K. Claxton et al., Bayesian value-of-infomation analysis - An application to a policy model of Alzheimer's disease, INT J TE A, 17(1), 2001, pp. 38-55
A dynamic programming approach to the efficient design of clinical trials
Authors: Claxton, K Thompson, KM
Citation: K. Claxton et Km. Thompson, A dynamic programming approach to the efficient design of clinical trials, J HEALTH EC, 20(5), 2001, pp. 797-822
Decision analytic modelling in the economic evaluation of health technologies - A consensus statement
Authors: Akehurst, R Anderson, P Brazier, J Brennan, A Briggs, A Buxton, M Cairns, J Calvert, N Claxton, K Dixon, S Fryback, D Gallivan, S Green, C Lloyd, A McCabe, C Mitchell, A Nicholl, J O'Brien, B Roberts, J Sculpher, M Severens, H Sullivan, S Veenstra, D
Citation: R. Akehurst et al., Decision analytic modelling in the economic evaluation of health technologies - A consensus statement, PHARMACOECO, 17(5), 2000, pp. 443-444
Assessing quality in decision analytic cost-effectiveness models - A suggested framework and example of application
Authors: Sculpher, M Fenwick, E Claxton, K
Citation: M. Sculpher et al., Assessing quality in decision analytic cost-effectiveness models - A suggested framework and example of application, PHARMACOECO, 17(5), 2000, pp. 461-477
Selecting treatments: a decision theoretic approach
Authors: Claxton, K Lacey, LF Walker, SG
Citation: K. Claxton et al., Selecting treatments: a decision theoretic approach, J ROY STA A, 163, 2000, pp. 211-225
The FDA's regulation of health economic information
Authors: Neumann, PJ Claxton, K Weinstein, MC
Citation: Pj. Neumann et al., The FDA's regulation of health economic information, HEAL AFFAIR, 19(5), 2000, pp. 129-137
Redefining the analytical approach to pharmacoeconomics
Authors: Luce, BR Claxton, K
Citation: Br. Luce et K. Claxton, Redefining the analytical approach to pharmacoeconomics, HEALTH ECON, 8(3), 1999, pp. 187-189
Bayesian approaches to the value of information: Implications for the regulation of new pharmaceutical
Authors: Claxton, K
Citation: K. Claxton, Bayesian approaches to the value of information: Implications for the regulation of new pharmaceutical, HEALTH ECON, 8(3), 1999, pp. 269-274
The irrelevance of inference: a decision-making approach to the stochasticevaluation of health care technologies
Authors: Claxton, K
Citation: K. Claxton, The irrelevance of inference: a decision-making approach to the stochasticevaluation of health care technologies, J HEALTH EC, 18(3), 1999, pp. 341-364
Risultati: 1-10 |